newsfilter
← Latest News
GlobeNewswire·

Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference

  • Oruka Therapeutics, Inc. (NASDAQ: ORKA) announced attendance at the 2026 Morgan Stanley Global Healthcare Conference in New York, NY from September 14-16, 2026.
  • The company is developing novel biologics for chronic skin diseases including plaque psoriasis & hidradenitis suppurativa.
  • Oruka aims to achieve high rates of disease clearance with dosing frequencies as low as once or twice a year.
  • Investor contact is Alan Lada, reachable at (650)-606-7911 or alan.lada@orukatx.com.